The following publication containing safety events was reviewed on 26 nov 2018: title: ultrasound-assisted catheter-directed thrombolysis compared with anticoagulation alone for treatment of intermediate-risk pulmonary embolism authors: andrew j.Schissler, robert j.Gylnn, piotr s.Sobieszczyk and aaron b.Waxman facility: (b)(6) hospital/(b)(6) medical school.This study sought to evaluate any lasting advantage of uacdt (ultrasound-assisted catheter-directed thrombolysis) on mortality and resolution of rv dysfunction in intermediate-risk pe at a large academic medical center.Adults aged <86 years admitted with intermediate risk pe from 2011 to 2016 were retrospectively identified.Outcomes including length of stay (los), bleeding complications, resolution of rv dysfunction, and mortality were compared between patients who received uacdt and those managed with anticoagulation alone.A total of 104 patients were included in the analysis, 65 of whom received uacdt.One "paitent" died before discharge in the uacdt cohort due to massive hemothorax confirmed on autopsy.All other safety events reported are considered to be unrelated to ekos.The relationship between the fatal massive hemothorax and the ekos device/procedure is unknown.
|